Dietary supplementation with 1,200 mg/d calcium carbonate didn't prevent fractures in an ambulatory elderly population because compliance was low. Those who took it, however, benefited.
Dietary supplementation with 1,200 mg/d calcium carbonate didn't prevent fractures in an ambulatory elderly population because compliance was low. Those who took it, however, benefited.
The findings come from a 5-year, double-blind, placebo-controlled study of almost 1,500 women over the age of 70. The authors found that while calcium supplementation did not significantly reduce fracture risk (hazard ratio 0.87; 95% CI; 0.67–1.12), it was because almost half the women (43%) didn't comply with the treatment regimen. In the 56.8% of women who took at least 80% of their tablets (calcium or placebo), the women who were receiving calcium had a hazard ratio for fracture of 10.2% versus 15.4% in the women receiving placebo (0.66; 95% CI; 0.45–0.97). The calcium-treated patients also had better quantitative ultrasonography findings of the heel, better femoral neck and whole-body dual x-ray absorptiometry data, and better bone strength.
The only adverse event that was increased in the treated group versus the placebo group was constipation.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More